Tandem Diabetes Care, Inc. TNDM

15.72 0.50 3.29% as of 25 Sep
Market cap
$1.1B
P/E
0.0×
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 627.17 0.00 0.00 0.00 0.00
P/S ratio
0.76 0.13 9.94 9.63 11.70 13.49 3.57 2.46 2.51 1.46
P/FCF ratio
0.00 0.00 0.00 156.46 0.00 107.95 380.50 0.00 0.00 0.00
P/Operating CF
(4.73) (1.24) 129.30 179.38 382.98 482.95 491.12 (255.07) 219.98 151.08
P/B ratio
0.00 0.00 13.92 17.89 15.93 21.89 6.50 5.87 8.96 9.53
Price to Tangible BV
0.00 0.00 14.04 17.96 16.32 22.25 6.57 5.96 9.13 9.85
EV/Sales
1.04 0.71 9.66 9.18 11.13 13.01 3.15 2.22 2.37 1.47
EV/EBITDA
0.00 0.00 0.00 0.00 491.73 236.86 0.00 0.00 0.00 0.00
EV/Operating CF
(1.43) (1.16) (213.43) 79.35 225.12 82.08 50.03 (52.11) 91.95 (153.92)
EV/FCF
(1.25) (1.07) (156.04) 149.17 (728.34) 104.05 336.09 (19.87) (34.69) (15.13)
Quick Ratio
2.12 0.97 2.48 2.24 5.46 5.57 4.43 2.94 2.24 1.89
Current Ratio
2.93 1.78 2.83 2.78 6.14 6.15 5.14 3.83 2.93 2.55
Net Debt/EBITDA
(0.32) (1.11) 3.53 14.49 (24.96) (8.87) 4.61 0.86 1.57 (0.10)
Debt/Assets
70.25% 80.28% 0.00% 4.29% 28.33% 31.10% 26.90% 29.92% 31.86% 35.19%
Debt/Equity
(13.32) (2.63) 0.00 0.07 0.55 0.65 0.64 0.91 1.17 2.00
Asset Turnover
0.71 1.04 1.22 1.36 0.96 0.87 0.82 0.75 0.98 1.10
Operating CF/Net income
0.73 0.91 0.07 (1.69) (0.72) 7.15 (0.53) 0.14 (0.25) 0.05
Capex/Depreciation
(1.65) (0.83) (0.37) (3.55) (1.68) (1.48) (2.10) (2.40) (4.01) (1.27)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(290.04%) 416.44% (240.11%) (15.17%) (12.25%) 3.89% (21.67%) (59.08%) (33.30%) (97.88%)
ROA
(70.38%) (70.31%) (81.30%) (9.30%) (6.60%) 1.92% (9.66%) (22.20%) (10.00%) (22.15%)
ROIC
(278.83%) (118.44%) (1,240.85%) (32.14%) (5.90%) 15.60% (54.60%) (111.48%) (46.57%) (67.83%)
Return on Tangible Assets
(105.60%) (153.10%) (88.37%) (11.81%) (5.89%) 2.13% (12.56%) (35.38%) (17.28%) (44.60%)
Average Days of Receivables
48.40 70.53 69.86 46.93 60.14 57.51 52.26 51.53 44.48 59.53
Research and Development Expense of Revenue
22.33% 19.20% 15.90% 12.48% 12.74% 13.10% 21.24% 33.22% 21.15% 26.44%
Selling, General and Administrative Expense of Revenue
98.32% 80.28% 57.23% 45.74% 41.08% 37.21% 41.90% 47.14% 41.46% 43.85%
Intangible Assets out of Total Assets
0.02 0.02 0.00 0.00 0.01 0.01 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
13.84% 11.74% 12.91% 16.03% 11.71% 8.64% 10.60% 11.78% 10.78% 9.10%
Graham Net Nets
(0.41) (4.18) 0.06 0.04 0.05 0.04 0.08 0.06 0.01 (0.07)
Graham Number
34.51 43.29 0.00 0.00 0.00 6.09 0.00 0.00 0.00 0.00
Earnings Yield
(130.00%) (638.58%) (9.35%) (0.74%) (0.61%) 0.16% (3.30%) (12.14%) (4.05%) (13.97%)
Free Cash Flow Yield
(109.32%) (498.82%) (0.62%) 0.64% (0.13%) 0.93% 0.26% (4.53%) (2.72%) (6.69%)
Revenue per Share
27.56 18.95 3.82 6.19 8.18 11.16 12.49 11.51 14.37 15.08
Operating CF per Share
(20.01) (11.65) (0.17) 0.72 0.40 1.77 0.79 (0.49) 0.37 (0.14)
Capex per Share
(2.92) (1.01) (0.06) (0.33) (0.53) (0.37) (0.67) (0.79) (1.00) (0.30)
Free Cash Flow per Share
(22.93) (12.66) (0.23) 0.38 (0.12) 1.39 0.12 (1.28) (0.63) (0.44)
Cash per Share
18.17 2.50 2.68 3.02 7.95 9.90 9.62 7.20 6.70 4.35
Shareholders Equity per Share
(1.94) (5.13) 2.73 3.33 6.01 6.87 6.86 4.83 4.02 2.31
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(1.94) (5.13) 2.73 3.33 6.01 6.87 6.86 4.83 4.02 2.31
Free Cash Flow
(70.10) (71.85) (11.30) 22.37 (7.62) 87.85 7.51 (83.41) (41.41) (29.67)
Working Capital
60.62 28.07 121.60 176.75 533.38 679.66 684.69 552.73 477.44 375.42
Capital Expenditures
(8.93) (5.72) (2.99) (19.54) (32.29) (23.51) (42.95) (51.60) (65.63) (19.95)
Net Current Asset Value
(26.23) (60.34) 112.87 145.01 287.13 339.50 237.14 108.96 19.93 (107.80)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 403.50 0.00 0.00 0.00 0.00
Capex to Sales
0.11 0.05 0.02 0.05 0.06 0.03 0.05 0.07 0.07 0.02
Net Profit Margin
(99.05%) (67.87%) (66.68%) (6.83%) (6.89%) 2.21% (11.81%) (29.77%) (10.21%) (20.17%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 418.61 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.29 0.35 0.47 0.17 0.38 0.32 0.30 0.28 0.21 0.19
Cash ROIC
(61.90%) (139.30%) (9.78%) 2.33% (2.40%) 4.56% (1.35%) (10.16%) (5.34%) (12.31%)
Accounts Receivable Turnover
6.68 6.73 6.57 8.86 7.75 7.29 7.11 6.79 8.54 7.25
Accounts Payable Turnover
9.52 10.03 15.71 13.68 13.41 14.25 9.27 7.22 9.56 10.21
Inventory Turnover
3.13 2.64 4.01 4.87 4.23 4.94 4.32 2.82 2.93 3.37
Average Days of Payables
45.21 29.60 26.49 38.53 27.27 31.33 52.40 47.63 36.23 36.65
Days of Inventory on Hand
127.54 155.14 77.22 106.56 97.60 76.61 104.47 151.69 121.18 100.27
Average Receivables
12.61 15.98 27.99 40.89 64.39 96.46 112.72 110.14 110.07 140.04
Average Payables
6.37 6.33 5.99 12.28 17.78 22.92 41.88 52.66 47.16 45.90
Average Inventory
19.37 24.09 23.44 34.48 56.40 66.14 89.83 134.53 153.77 139.19
Average Assets
118.56 103.87 150.82 266.20 521.26 810.78 978.96 1,002.72 960.16 924.39
Average Common Equity
28.77 (17.54) 51.06 163.13 280.64 399.71 436.53 376.79 288.37 209.13

Fold the line items

Columns are period end dates